[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:venous-thromboembolism":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":155,"states":156},"Venous Thromboembolism",23,18,[8,15,21,28,35,41,48,55,61,67,73,79,85,91,97,103,109,115,121,128,134,142,149],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT06957366","Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure",[],"RECRUITING","2026-08-26T02:16:39.977107Z","2026-05-05T02:43:29.340116Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06451003","Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery",[],"2026-08-26T02:19:08.084946Z","2026-05-05T02:43:29.200167Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":26,"content_modified":27},"NCT07410117","REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis",[25],"Phase 3","2026-08-26T02:17:48.768272Z","2026-07-05T05:32:16.680342Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":33,"content_modified":34},"NCT06886516","Apixaban in Thrombocytopenia",[32],"Early Phase 1","2026-08-26T02:15:47.754948Z","2026-05-05T02:35:31.860430Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":39,"content_modified":40},"NCT07493304","Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers",[25],"2026-08-26T02:17:05.997056Z","2026-05-29T15:36:40.231786Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":46,"content_modified":47},"NCT06831474","Excretion of Rivaroxaban in Human Breast Milk",[45],"Phase 1","2026-08-26T02:17:20.511551Z","2026-05-05T02:43:29.641008Z",{"nct_id":49,"title":50,"phases":51,"status":12,"updated_at":53,"content_modified":54},"NCT04924322","Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies",[52],"Phase 2\u002FPhase 3","2026-08-26T02:16:55.892527Z","2026-05-05T02:43:29.387642Z",{"nct_id":56,"title":57,"phases":58,"status":12,"updated_at":59,"content_modified":60},"NCT06939803","AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.",[],"2026-08-26T02:18:35.425468Z","2026-05-05T02:43:28.871519Z",{"nct_id":62,"title":63,"phases":64,"status":12,"updated_at":65,"content_modified":66},"NCT03728166","Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)",[],"2026-08-26T02:15:46.655893Z","2026-05-05T02:43:27.979423Z",{"nct_id":68,"title":69,"phases":70,"status":12,"updated_at":71,"content_modified":72},"NCT07399977","Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism",[],"2026-08-26T02:18:58.958025Z","2026-05-05T02:43:28.714239Z",{"nct_id":74,"title":75,"phases":76,"status":12,"updated_at":77,"content_modified":78},"NCT05628207","Evaluation of the SCALED (SCaling AcceptabLE cDs)",[],"2026-08-26T02:18:17.007929Z","2026-05-13T02:55:06.365460Z",{"nct_id":80,"title":81,"phases":82,"status":12,"updated_at":83,"content_modified":84},"NCT03407469","Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization",[],"2026-08-26T02:18:20.384845Z","2026-05-13T02:55:06.123653Z",{"nct_id":86,"title":87,"phases":88,"status":12,"updated_at":89,"content_modified":90},"NCT02832245","Computerized Registry of Patients With Venous Thromboembolism (RIETE)",[],"2026-08-26T02:19:07.104270Z","2026-05-13T02:55:06.101564Z",{"nct_id":92,"title":93,"phases":94,"status":12,"updated_at":95,"content_modified":96},"NCT01158482","Filter Initial & Long Term Evaluation After Placement and Retrieval Registry",[],"2026-08-26T02:17:35.666428Z","2026-05-13T02:55:06.067765Z",{"nct_id":98,"title":99,"phases":100,"status":12,"updated_at":101,"content_modified":102},"NCT05881798","Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study",[],"2026-08-26T02:15:54.846520Z","2026-05-13T02:55:06.390516Z",{"nct_id":104,"title":105,"phases":106,"status":12,"updated_at":107,"content_modified":108},"NCT05756244","PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism",[],"2026-08-26T02:18:51.833592Z","2026-05-13T02:55:06.375311Z",{"nct_id":110,"title":111,"phases":112,"status":12,"updated_at":113,"content_modified":114},"NCT07350499","Aspiration Thrombectomy Using the Symphony or Prodigy System",[],"2026-08-26T02:16:44.178623Z","2026-07-05T05:32:16.676788Z",{"nct_id":116,"title":117,"phases":118,"status":12,"updated_at":119,"content_modified":120},"NCT06608758","End Diagnostic Overshadowing:Addressing Ableism in Diagnoses",[],"2026-08-26T02:18:31.164304Z","2026-05-13T02:55:06.556822Z",{"nct_id":122,"title":123,"phases":124,"status":125,"updated_at":126,"content_modified":127},"NCT06628778","Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).",[25],"NOT_YET_RECRUITING","2026-08-26T02:16:59.895916Z","2026-05-05T02:43:28.335543Z",{"nct_id":129,"title":130,"phases":131,"status":125,"updated_at":132,"content_modified":133},"NCT04229758","Restarting Anticoagulation After Traumatic Intracranial Hemorrhage",[25],"2026-08-26T02:17:25.718160Z","2026-05-05T02:43:27.829919Z",{"nct_id":135,"title":136,"phases":137,"status":139,"updated_at":140,"content_modified":141},"NCT05794165","Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism",[138],"Phase 2","ENROLLING_BY_INVITATION","2026-08-26T02:17:24.721169Z","2026-06-16T05:54:08.087000Z",{"nct_id":143,"title":144,"phases":145,"status":146,"updated_at":147,"content_modified":148},"NCT04766216","Warfarin Patient Self-management Implementation in the US Healthcare System",[],"UNKNOWN","2026-08-03T03:23:54.120018Z","2026-05-05T02:43:29.153189Z",{"nct_id":150,"title":151,"phases":152,"status":146,"updated_at":153,"content_modified":154},"NCT06232551","Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism",[],"2026-08-03T03:26:55.873278Z","2026-05-05T02:43:28.369445Z",[],[157,161,165,168,172,175,179,182],{"state":158,"count":159,"slug":160},"Florida",7,"florida",{"state":162,"count":163,"slug":164},"New York",6,"new-york",{"state":166,"count":163,"slug":167},"Texas","texas",{"state":169,"count":170,"slug":171},"Illinois",5,"illinois",{"state":173,"count":170,"slug":174},"Massachusetts","massachusetts",{"state":176,"count":177,"slug":178},"California",3,"california",{"state":180,"count":177,"slug":181},"Connecticut","connecticut",{"state":183,"count":177,"slug":184},"Pennsylvania","pennsylvania"]